Skip to main content
. 2023 Mar 27;12(3):396–404. doi: 10.21037/tp-23-86

Table 1. Clinical and laboratory characteristics of the GMPP and RMPP patients.

Variables GMPP (n=30) RMPP (n=35) P value
Characteristics
   Male/female 14/16 16/19 0.939
   Age, years 4.6±2.9 4.8±2.6 0.766
   Hospitalization time (d) 7 (6, 9) 11 (9, 14) <0.001
Signs and symptoms
   Total fever duration (d) 6.4±1.81 12.8±5.6 <0.001
   Lung rales, n (%) 11 (36.7) 15 (42.9) 0.612
   Lung wheezing, n (%) 8 (26.7) 7 (20.0) 0.525
Laboratory characteristics
   WBC (×109/L) 6.6 (5.0, 8.0) 8.0 (6.3, 10.7) 0.048
   N% 58.3 (46.1, 65.3) 62.5 (48.2, 73.2) 0.421
   L% 36.4 (28.7, 46.3) 32.7 (20.2, 43.1) 0.263
   PLT (×109/L) 259.0 (204.0, 310.3) 292.0 (257.5, 336.5) 0.062
   CRP (mg/L) 7.5 (3.3, 17.8) 11.5 (4.9, 35.6) 0.167
   ALT (U/L) 13.4 (10.0, 17.1) 14.4 (11.2, 21.4) 0.157
   AST (U/L) 30.4 (25.6, 37.6) 32.7 (25.1, 43.0) 0.563
   LDH (U/L) 377.7 (318.1, 451.2) 450.5 (323.9, 534.9) 0.171
   Humoral immunity
    IgG/g·L−1 7.9±3.3 9.7±3.1 0.031
    IgA/g·L−1 0.77 (0.38, 1.28) 1.25 (0.56, 1.94) 0.186
    IgM/g·L−1 1.2 (0.9, 1.5) 1.7 (1.2, 2.0) 0.036
   Cellular immunity
    CD3+ 64.4±8.7 67.6±10.3 0.185
    CD3+CD4+ 34.2±6.5 34.4±7.7 0.900
    CD3+CD8+ 25.1±6.6 28.4±8.2 0.09
    CD4/CD8 1.6 (1.0, 1.7) 1.1 (1.0, 1.6) 0.195
    CD3-CD19+ 21.1 (18.2, 29.4) 16.0 (12.1, 19.6) 0.002
    CD3-CD (16+56+) + 9.6 (7.3, 14.4) 11.5 (7.1, 17.8) 0.545
    CD19+CD23+ 10.3 (8.3, 13.3) 7.5 (5.8, 10.9) 0.025

Data are expressed as the mean ± standard deviation or median (25th–75th interquartile range). GMPP, general mycoplasma pneumoniae pneumonia; RMPP, refractory mycoplasma pneumoniae pneumonia. WBC, white blood cell count; N%, proportion of neutrophils; L%, proportion of lymphocytes; PLT, platelets; ALT, alanine aminotransferase; AST, aspartate aminotransferase; CRP, C-reactive protein; LDH, lactate dehydrogenase; IgA, immunoglobulin A; IgG, immunoglobulin G; IgM, immunoglobulin M.